Publications found:
12,947
Sort by:
JAPAN DOMESTIC PHARMA- Competitive Landscape of Leading Therapy Classes - UPDATE
US$ 600.00
In this updated issue of ‘Japan-Domestic Pharma Market Summary’ for 2012, we present major 10 Thx Class in Japan which covers ~40% of total Japan domestic pharma market (~¥8.0 trillion). This will ... breakthroughs in each class – which includes products from all pharma companies operating in Japan including MNCs.
March 2012
27 pages
ROCHE - CHUGAI, RoActemra monotherapy Superior to Humira: ADACTA Study
US$ 90.00
In a Ph IV ADACTA monotherapy study, RoActema has shown superior improvement ... the biologic RA market (~ $10B). The data should support Roche’s sNDA for 1st line approval in the US (submitted in December ... in EU where Actemra is already approved in first line, Roche will file for a label change based on this data.
March 2012
2 pages
Analyzing the Tobacco Industry in Japan
US$ 320.00
... . Aruvians Rsearch analyzes the Japanese tobacco industry in its research offering Analyzing the Tobacco Industry in Japan. The report is an in-depth profile of the tobacco industry in Japan as well as the ...
March 2012
75 pages
DAIICHI SANKYO - Growth Story Remains Intact!
US$ 90.00
... rating on Daiichi Sankyo (DS) while revising down 12-months TP to ¥1,850 on account of incorporating likely impact of Ranbaxy settlement cost and tax reforms in Japan. Going forward ...
February 2012
2 pages
Future Japanese Tumor Marker Testing Market Outlook
US$ 5,360.00
Highlights Comprehensive 590-page analysis of the Japanese tumor marker testing market. Major issues pertaining to the Japanese laboratory practice, as well as key ... , lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others. Ten-year test volume and sales forecasts over for ...
February 2012
590 pages
Future Japanese Nucleic Acid Testing Market Outlook
US$ 6,000.00
Highlights Comprehensive 850-page market segmentation analysis of the Japanese NAT market. Major issues pertaining to the Japanese NAT laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. An ...
February 2012
850 pages
Future Japanese Microbiology Testing Market Outlook
US$ 6,240.00
Highlights Comprehensive 976-page analysis of the Japanese microbiology testing market. Major issues pertaining to the Japanese microbiology laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. ...
February 2012
976 pages
Future Japanese Transfusion Diagnostic Testing Market Outlook
US$ 5,440.00
... next ten years. Ten-year volume and sales forecasts for 40 blood typing, grouping and infectious disease screening tests, including NAT procedures performed in Japanese transfusion testing hospitals, and commercial laboratories. Annual placements and installed base estimates for major automated and semi- ...
February 2012
426 pages
Japan Generics Market Analysis
US$ 1,000.00
Japan is the world’s second largest pharmaceutical markets in the world, but due to public perception, the share of generic drugs has remained low in it. However, worried over rising healthcare expens...
February 2012
55 pages
Japan’s Biotechnology Industry - Porter’s Five Forces Strategy Analysis
US$ 175.00
... is a critical element of national power. Advances in biotechnology are resulting in novel biomedical and pharmaceutical products and processes ... the world’s citizens. Aruvian's R'search analyzes the Japanese Biotechnology Industry in the Michael Porter’s Five Forces Analysis. It uses concepts developed in ...
February 2012
20 pages
Pharmaceutical Industry in Japan
US$ 300.00
... you a complete analysis of the Pharmaceutical Industry in Japan. The report covers a brief profile of the global pharmaceutical industry, the TRIPS agreement, ... , competition in the industry, and the key players in the pharmaceutical industry in Japan – complete with a SWOT analysis of the leading companies in ...
February 2012
100 pages
Outlook 2012 - Japanese Pharma - Cautious Ideas to Seize Value in Happening 2012!
US$ 2,000.00
‘Japanese Pharma Top & Bottom Picks’. Our analysis suggests that 2012 is going to be a happening year for Japan Pharma on multiple fronts – while next layer of reform ... largely supporting generic companies, select innovators from Japan hold value in term of their R&D. 2012 will unfold much of this value and ...
December 2011
78 pages
TOWA - Performance Will Outcast New ‘Mid Term Plan’
US$ 140.00
In Towa’s MTP announcement, it has projected single digit revenue growth and assumed there will not be any ‘New Major Reform’ by Govt to enhance ... in dispensing fee and incentives to doctors will boost Towa’s revenue (as 90%+ its revenue from these two segments), 2) Towa management is taking the right decision ...
November 2011
7 pages
ASTELLAS - Commercialization Terms Fade MDV-3100 Clinical Success for Astellas!
US$ 90.00
Astellas released solid interim data from AFFIRM trial on MDV-3100 ... this solid data, we find a limited bottom line impact on Astellas due to its commercialization agreement with Medivation. Under the agreement, Medivation will ... receive upto $650m milestone payment which leaves a little for Astellas’s investor.
November 2011
3 pages
DAIICHI SANKYO - Edoxaban Gets Edge as Key Japanese Factor-Xa Inhibitors Fall!
US$ 140.00
Recent failures of Edoxaban’s key competitor factor-Xa inhibitors from Japan - YM 150 (Astellas) and TAK-442 (Takeda), the closest candidate in Japan now is Xarelto ... years away from hitting the market. Edoxaban is the first and only approved factor-Xa inhibitor in Japan for prevention of VTE, though Japanese ...
September 2011
4 pages
Japan Steel Industry Analysis
US$ 800.00
Single User PDF Format: US$ 800.00 Multi-User License: US$ 1,300.00 Hard Copy: US$ 900.00 CD-ROM: US$ 900.00 Japan has positioned itself as a strategic player globally as the second largest steel pro...
August 2011
75 pages
Strategic Assessments of Leading Japanese Diagnostic Imaging Market Players
US$ 7,600.00
... , annually updated and cost-effective information based on performance, capabilities, goals and strategies of the leading Japanese diagnostic imaging companies. To help current suppliers realistically assess their financial, technological and marketing capabilities vis-a-vis the leading competitors. To ...
August 2011
839 pages
Eisai - Catalysts Too Weak to Mitigate Key Patent Expiries
US$ 140.00
... Nov-10 and May-13 respectively); together they contributed ~56% of revenue in FY 03/11. Eisai solely depends on catalysts coming out of its pipeline. Following Halaven approval ... , Eisai has three late stage candidates E-2007/ perampanel ...
August 2011
8 pages
TAKEDA - Multiple Challenges Blur Future!
US$ 140.00
There are three major concerns for Takeda – 1) Takeda has got European exposure by the Nycomed acquisition, but as both ... is expected. 2) Safety related issues with Actos affects market prospects of Takeda’s key candidate Aloglipin’s combination drug with Actos and, 3) Pipeline ...
August 2011
8 pages
Mirabegron Gets JP Approval – Expecting US Filing & Approval In Time!
US$ 90.00
... rating on Astellas following announcement of JP approval for Betanis / mirabegron (β3-AR agonist, overactive bladder syndrome (OAB). Mirabegron is a key strategic product for ... able to maintain its leadership in the growing OAB market. Mirabegron will be targeted for those patients who are intolerant to ...
June 2011
4 pages
ASTELLAS - DPP IV Royalty Sold Below Par - Another Wrong Move by the Management!
US$ 140.00
Astellas has announced to sell future royalty of DPP IV inhibitors for $609m to Royalty Pharma, which it has acquired along with OSI acquisition. We do not ... case! Presently royalty earned from marketed drugs and most advanced pipeline candidate translate into > $750m for Astellas. With modest efficacy ...
June 2011
5 pages
Analyzing Fixed Line Telecommunication Industry in Japan
US$ 250.00
... fixed line telecommunication industry in Japan. The report begins with an analysis of the basics of the telecommunication industry and then moves on to analyze the industry in Japan. The report analyzes the ...
June 2011
60 pages
Analyzing the Engines Market in Japan
US$ 250.00
... – Analyzing the Engines Market in Japan. For the purposes of this research report, the Japanese engines market is made up of stationary engines used for non-utility power generation. A stationary engine is an engine ...
June 2011
50 pages
Japan Diabetes Market Report & Forecast 2011-2016
US$ 750.00
IMARC’s new report “Japan Diabetes Market Report & Forecast 2011-2016” provides an analytical and statistical insight into the Japanese diabetes market. The report provides both current and future tre...
April 2011
37 pages
Japanese Generic Market Forecast to 2013
US$ 800.00
Single User PDF Format: US$ 800.00
Multi-User License: US$ 1,400.00
Hard Copy: US$ 900.00
CD-ROM: US$ 900.00 Generic drugs are produced and distributed without patent protection and ma...
March 2011
45 pages
Consumption Situation of High Intensity Sweeteners in Japan
US$ 435.00
... aspects Situation of rival products and eating habit on sweet products in Japan Detailed description on high intensity sweeteners consumption pattern, market size in Japan Demand forecast on high intensity sweeteners industry in Japan ...
February 2011
4 pages
Production Situation of High Intensity Sweeteners in Japan
US$ 435.00
... into many sub-reports with different specific themes. Production of High Intensity Sweetener in Japan is one of the sub-reports. Highlights ... policies on high intensity sweeteners market, either positive or negative aspects Situation of rival products and eating habit on sweet products in Japan Introduction to ...
February 2011
3 pages
Survey of HIS in Japan
US$ 2,700.00
... , we separated it into many sub-reports with different specific themes. Survey of High Intensity Sweetener in Indonesia is one of the sub-reports. ... , consumption habits, etc. 3 Acquaintance about market of major 7 categories of HIS: stevia sweetener, Cyclamate, aspartame, saccharin, etc. 4 Find out where ...
February 2011
16 pages
Trade Situation of High Intensity Sweeteners in Japan
US$ 650.00
... , we separated it into many sub-reports with different specific themes. Trade Situation of High Intensity Sweetener in Indonesia is one of the sub-reports. Highlights of this sub ...
February 2011
4 pages
Japan LNG Export and Import Markets (2010)- Outlook of Demand, Capacity, Trades, Prices, Contracts and Market Structures to 2020
US$ 2,499.00
LNGReports launched its brand new “Japan LNG Export and Import Markets (2010)- Outlook of Demand, Capacity, Trades, Prices, Contracts and Market Structures to 2020”, a comprehensive report on Japan LN...
January 2011
150 pages
Japan Insurance Market Intelligence: 2011 Edition
US$ 600.00
... market is experiencing a slow growth mainly because of economic challenges which the country is facing due to global economic slowdown. Japan's non-life insurance sector ...
January 2011
21 pages
Telemarketing: Market Research Report
US$ 3,950.00
This report analyzes the US and Japanese markets for Telemarketing in US$ Million. Annual estimates and forecasts are provided for the period ... players such as AnswerNet Network, Contact America, Inc., Business Beanstalk Telemarketing Services and Call Center Solutions, Convergys Corporation, Intelemark, Quest ...
July 2010
186 pages
Japan: Agrochemicals: Market Intelligence (2020-2025)
US$ 2,250.00
... The report “Japan: Agrochemicals: Market Intelligence (2018-2022)” provides market intelligence on the different market segments, based on type, active ingredient, formulation, crop, and pest. Market size and forecast (2018-2022) has ...
June 2026
120 pages
The Japan Cloud and Data Centre Market
US$ 900.00
About the Report There are tenkey subsea fibre cables connecting Japan and two new subsea cable systems are planned from Japan including the following - ADC to be launhced in Q4 2020 and the SJC2 for...
June 2026
-
Japan: Data Centre Landscape 2022 to 2026
US$ 985.00
There are tenkey subsea fibre cables connecting Japan and two new subsea cable systems are planned from Japan including the following - ADC to be launhced in Q4 2020 and the SJC2 for launch in 2021. J...
June 2026
-
